Cochlear Limited that designs, manufactures and sells the Nucleus Cochlear implant along with the Bone Conduction Hearing Solution Baha osseointegrated bone conduction implant, with an estimated 250 000 cochlear implant/Baha recipients receiving a Cochlear Limited product since their establishment in 1981.By setting corporate goals for customer focus, organisational performance, and shareholder value, strategic thinking has leveraged our innovation into a very successful business.